Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The American Journal of Geriatric Pharmacotherapy

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjopharm.2009.02.006PMID 19281939PMCID PMC2738590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer

  2008cited by this paper
• Methylphenidate in the treatment of geriatric patients with vascular depression: a retrospective chart review.

  2008cited by this paper
• Methylphenidate for the Treatment of Apathy in Alzheimer Disease: Prediction of Response Using Dextroamphetamine Challenge

  2008cited by this paper
• Does Chirality Matter?: Pharmacodynamics of Enantiomers of Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder

  2008cited by this paper
• Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.

  2008cited by this paper
• Can Methylphenidate Reduce Fall Risk in Community‐Living Older Adults? A Double‐Blind, Single‐Dose Cross‐Over Study

  2008cited by this paper
• The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study

  2008cited by this paper
• An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy

  2008cited by this paper
• Psychostimulants for depression.

  2008cited by this paper
• Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD

  2008cited by this paper
• Drug therapy for the management of cancer related fatigue.

  2008cited by this paper
• Patient-Controlled Methylphenidate for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial

  2007cited by this paper
• Methylphenidate-Induced Autoimmune Hepatitis

  2007cited by this paper
• Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial

  2007cited by this paper
• Depression, Self-Care, and Medication Adherence in Type 2 Diabetes

  2007cited by this paper
• A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.

  2007cited by this paper
• Treatment of apathy with methylphenidate.

  2007cited by this paper
• A phase II study of methylphenidate for the treatment of fatigue

  2006cited by this paper
• A Randomized, Double-blind, Placebo-controlled Trial of Augmentation With an Extended Release Formulation of Methylphenidate in Outpatients With Treatment-Resistant Depression

  2006cited by this paper
• Methylphenidate for α-interferon induced depression

  2006cited by this paper
• Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

  2006cited by this paper
• Guidelines for the Pharmacologic Treatment of Neurobehavioral Sequelae of Traumatic Brain Injury

  2006cited by this paper
• Use of methylphenidate in patients with cancer

  2006cited by this paper
• Methylphenidate for alpha-interferon induced depression.

  2006cited by this paper
• Cerebral vasculitis following oral methylphenidate intake in an adult: A case report

  2006cited by this paper
• Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.

  2006cited by this paper
• Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial.

  2006cited by this paper
• Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study.

  2005cited by this paper
• A phase III, randomized placebo-controlled trial of the safety and efficacy of d-MPH as new treatment of fatigue and "chemobrain" in adult cancer patients

  2005cited by this paper
• Supraventricular tachycardia associated with methylphenidate treatment in a heart transplant recipient.

  2005cited by this paper
• Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.

  2005cited by this paper
• A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.

  2005cited by this paper
• Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury

  2005cited by this paper
• Modafinil as an alternative to methylphenidate as augmentation for depression treatment.

  2005cited by this paper
• Methylphenidate May Treat Apathy Independent of Depression

  2005cited by this paper
• Effects of methylphenidate on cognition and apathy in normal pressure hydrocephalus: A case study and review

  2005cited by this paper
• Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects

  2004cited by this paper
• Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure.

  2004cited by this paper
• Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

  2004cited by this paper
• Psychostimulants and delirium in patients receiving palliative care

  2004cited by this paper
• Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture

  2004cited by this paper
• Polymorphisms of the Dopamine Transporter Gene

  2004cited by this paper
• Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.

  2004cited by this paper
• The role of depressive symptoms in recovery from injuries to the extremities in older persons. A prospective study

  2003cited by this paper
• Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.

  2003cited by this paper
• Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial.

  2003cited by this paper
• Differential Effects of Premorbid Physical and Emotional Health on Recovery from Acute Events

  2002cited by this paper
• Palliative uses of methylphenidate in patients with cancer: a review.

  2002cited by this paper
• An Evaluation of the Effects of Methylphenidate on Outcomes in Adult Epilepsy Patients.

  2002cited by this paper
• Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults

  2002cited by this paper
• Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study

  2002cited by this paper
• Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate.

  2002cited by this paper
• Depression in advanced disease: a systematic review - Part 1. Prevalence and case finding

  2002cited by this paper
• Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project.

  2002cited by this paper
• Depression in advanced disease: a systematic review Part 1. Prevalence and case finding

  2002cited by this paper
• A phase II study of methylphenidate for depression in advanced cancer

  2001cited by this paper
• Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study

  2001cited by this paper
• A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.

  2001cited by this paper
• Methylphenidate augmentation of citalopram in elderly depressed patients.

  2001cited by this paper
• Methylphenidate improves HIV-1-associated cognitive slowing.

  2001cited by this paper
• Methylphenidate in a Patient with Depression and Respiratory Insufficiency

  2001cited by this paper
• Toward Individualized Evidence‐Based Medicine: Five “N of 1” Trials of Methylphenidate in Geriatric Patients

  2001cited by this paper
• Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive care unit.

  2000cited by this paper
• Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers.

  2000cited by this paper
• Psychotropic Drugs and Falls: New Evidence Pertaining to Serotonin Reuptake Inhibitors

  2000cited by this paper
• Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate

  2000cited by this paper
• Methylphenidate: its pharmacology and uses.

  2000cited by this paper
• Early augmentation of sertraline with methylphenidate.

  1999cited by this paper
• Algorithm for the treatment of major depression in patients with advanced cancer.

  1999cited by this paper
• Absence of Effect of Stimulants on the Pharmacokinetics of Desipramine in Children

  1999cited by this paper
• Depressive Symptoms and 3-Year Mortality in Older Hospitalized Medical Patients

  1999cited by this paper
• Treatment guidelines for geriatric mood disorders.

  1999cited by this paper
• Drugs and Falls in Older People: A Systematic Review and Meta‐analysis: I. Psychotropic Drugs

  1999cited by this paper
• Methylphenidate in terminal depression.

  1998cited by this paper
• Depression in hospitalized older patients with congestive heart failure.

  1998cited by this paper
• Potentiation of opioid analgesia by psychostimulant drugs: a review.

  1998cited by this paper
• Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.

  1998cited by this paper
• Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.

  1998cited by this paper
• Methylphenidate in post liver transplant patients.

  1998cited by this paper
• Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.

  1998cited by this paper
• Methylphenidate in terminal depression.

  1998cited by this paper
• Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with Amphetamine

  1997cited by this paper
• Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial.

  1997cited by this paper
• Relation between Symptoms of Depression and Health Status Outcomes in Acutely Ill Hospitalized Older Persons

  1997cited by this paper
• Methylphenidate treatment of negative symptoms in patients with dementia.

  1997cited by this paper
• Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study.

  1997cited by this paper
• Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain

  1997cited by this paper
• The neuropathology of schizophrenia.

  1996cited by this paper
• Use of stimulants in the medically ill.

  1996cited by this paper
• Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.

  1996cited by this paper
• Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.

  1996cited by this paper
• Combined treatment with moclobemide and methylphenidate for comorbid major depression and adult attention-deficit/hyperactivity disorder.

  1996cited by this paper
• Psychostimulants for depression in hospitalized cancer patients.

  1996cited by this paper
• Methylphenidate in the 'hard to wean' patient.

  1995cited by this paper
• Successful methylphenidate treatment of apathy after subcortical infarcts.

  1995cited by this paper
• Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients.

  1995cited by this paper
• Apathy: a treatable syndrome.

  1995cited by this paper
• Effects of Methylphenidate in HIV-Related Depression: A Comparative Trial with Desipramine

  1995cited by this paper
• A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics

  1995cited by this paper
• Sertraline with methylphenidate in an ICU patient.

  1995cited by this paper

• Risk Factors for Adverse Cardiac Events in Individuals Prescribed Stimulants Across the Lifespan

  2025cites this paper
• Low-Dose Methylphenidate Treatment for Apathy After Traumatic Brain Injury.

  2024cites this paper
• Palliative, End-of-Life, and Psychiatric Care of Patients with Advanced Renal Disease

  2022cites this paper
• Effectiveness of Pharmacotherapy for Depression after Adult Traumatic Brain Injury: an Umbrella Review

  2022influential citation
• The Antifatigue Mechanism of Buyang-huanwu Decoction as Revealed by Serum Metabolomics in an Endurance Swimming Rat Model

  2022cites this paper
• Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies

  2022cites this paper
• End‐of‐life and palliative care

  2022cites this paper
• Depression and Anxiety Disorders

  2021cites this paper
• Depression: A Challenge during Palliative Care

  2021cites this paper
• Lifetime evolution of ADHD treatment

  2021cites this paper
• Evidence That Methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks

  2021cites this paper
• Methylphenidate use in geriatric depression: A systematic review

  2021cites this paper
• Amphetamine-induced alteration to gaze parameters: A novel conceptual pathway and implications for naturalistic behavior.

  2020cites this paper
• Adult ADHD in Depressive Disorders

  2020cites this paper
• Use of cognitive enhancers: methylphenidate and analogs.

  2019cites this paper
• Weekday‐only chronic oral methylphenidate self‐administration in male rats: Reversibility of the behavioral and physiological effects

  2019cites this paper
• A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch

  2019influential citation
• Depression in the medically ill

  2019cites this paper
• The role of methylphenidate in the treatment of catatonia

  2019influential citation
• ADHD With Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical And Pharmacological Aspects Across The Lifespan.

  2019cites this paper
• Modeling the effects of methylphenidate on interference and evidence accumulation processes using the conflict linear ballistic accumulator

  2019cites this paper
• Moving from the old monoaminergic theory toward the emerging hypothesis in the rational design of rapid-onset novel antidepressants

  2019cites this paper
• Clinician’s Guide to ADHD Comorbidities in Children and Adolescents

  2018cites this paper
• Neuropharmacological classification of antidepressant agents based on their mechanisms of action

  2018cites this paper
• Approach to Depression in the Medically Ill

  2018cites this paper
• Psychopharmacology in Transplant Patients

  2018cites this paper
• Methylphenidate augmentation during antidepressant treatment for depression in HIV: a case report

  2018cites this paper
• Patterns and profiles of methylphenidate use both in children and adults

  2018cites this paper
• Predictors of Response and Remission to Antidepressants in Geriatric Depression: A Systematic Review

  2018cites this paper
• Challenges in management of Major Depression in patients with co-morbid medical conditions

  2018cites this paper
• Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period

  2018cites this paper
• Top Ten Tips Palliative Care Clinicians Should Know About Mental Health and Serious Illness

  2018cites this paper
• Palliative Care for Geriatric Psychiatric Patients with Life-Limiting Illness

  2018cites this paper
• Distinguishing and Managing Severe Psychological and Psychiatric Distress

  2018cites this paper
• Use of attention‐deficit/hyperactivity disorder medication among older adults in Denmark

  2018cites this paper
• ADHD and Bipolar Disorder

  2018cites this paper
• Place des psychotropes en oncologie

  2018cites this paper
• Randomized, double‐blind, placebo‐controlled study of methylphenidate for the treatment of depression in SSRI‐treated cancer patients receiving palliative care

  2017cites this paper
• The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness

  2017cites this paper
• Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia

  2017cites this paper
• Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities

  2017cites this paper
• Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

  2016cites this paper
• The Use of Methylphenidate in the Postoperative Management of Older Adults after Coronary Artery Bypass Surgery

  2016influential citation
• Fatigue and Major Depressive Disorder - A Systematic Review of Etiology, Maintenance, Diagnosis and Treatment

  2016cites this paper
• Syddansk Universitet Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 ( CES 1 ) Variants

  2016cites this paper
• Acute Inpatient Medical Settings

  2016cites this paper
• End of life care.

  2016cites this paper
• Antidepressant drug development: Focus on triple monoamine reuptake inhibition

  2015influential citation
• How should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design

  2015cites this paper
• Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases.

  2015cites this paper
• Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

  2015cites this paper
• Symptom management in the older adult: 2015 update.

  2015cites this paper
• Attention enhancing effects of methylphenidate are age-dependent.

  2015cites this paper
• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

  2015cites this paper
• Psychopharmacology in Medically Ill Patients

  2015cites this paper
• A Review of Psychostimulants for Adults With Depression.

  2015cites this paper
• [Psychiatric disorders in palliative care and at the end of life].

  2015cites this paper
• Hot and cold cognition in major depressive disorder

  2014cites this paper
• Depression in the Elderly

  2014cites this paper
• Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.

  2014cites this paper
• Prescribing practices in hospice patients with adult failure to thrive or debility

  2014cites this paper
• FPIN's Clinical Inquiries. Methylphenidate for management of fatigue in the palliative care setting.

  2014cites this paper
• An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder

  2014cites this paper
• Treatment of Somatoform Disorders and Other Somatic Symptom Conditions (Pain, Fatigue, Hot Flashes, and Pruritus)

  2014cites this paper
• Sleep Disorders and Fatigue: Special Issues in the Older Adult With Cancer

  2014cites this paper
• Wake-Promoting Pharmacotherapy for Psychiatric Disorders

  2014cites this paper
• Revisión sobre el uso del metilfenidato para el tratamiento de la astenia en pacientes paliativos

  2013cites this paper
• Research Priorities in Geriatric Palliative Care: Nonpain Symptoms

  2013cites this paper
• Chemotherapy in psychiatry

  2013cites this paper
• Antidepressant-Antianxiety Agents

  2013cites this paper
• Palliative Care Psychiatry: Update on an Emerging Dimension of Psychiatric Practice

  2013cites this paper
• [Psychostimulants in the treatment of depression].

  2013cites this paper
• [Use of methylphenidate in palliative patients with asthenia: a review].

  2013cites this paper
• Depression in Advanced Disease

  2013cites this paper
• The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective

  2012cites this paper
• End‐of‐Life and Palliative Care

  2012cites this paper
• Rapid improvement in medically ill elderly patients treated with methylphenidate for apathy

  2012cites this paper
• Depression in medically ill patients.

  2012cites this paper
• The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective

  2012cites this paper
• Better—but good enough? The first randomised controlled trial of psychostimulants for depressive symptoms in advanced cancer

  2012cites this paper
• Evidence-based treatment of depression in patients with cancer.

  2012cites this paper
• Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review

  2012cites this paper
• Managing grief and depression at the end of life.

  2012cites this paper
• Are gerontological nurses apathetic about apathy in older adults.

  2012cites this paper
• The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features.

  2012cites this paper
• The use of dopaminergic and stimulant drugs for the treatment of depression.

  2012cites this paper
• Epidemiology and management of depression in cancer patients

  2012cites this paper
• The use of psychostimulants in cancer patients

  2011cites this paper
• Fatigue in Parkinson's disease

  2011cites this paper
• Management of end-stage heart failure.

  2011cites this paper
• Geriatric depression: The use of antidepressants in the elderly Depression is a common but undertreated condition in the elderly.

  2011cites this paper
• Psychotropes et sujet âgé

  2011cites this paper
• [Neurologic and psychiatric implications of apathy].

  2010cites this paper
• The Assessment of Depressive Syndromes

  2010cites this paper
• Cuidados paliativos en pacientes con insuficiencia renal terminal

  2010cites this paper
• Behavioral phenotype in the 9q subtelomeric deletion syndrome: A report about two adult patients

  2010cites this paper
• Brain Metastases

  2010cites this paper
• Les antidépresseurs en oncologie : spécificités et particularités

  2010cites this paper